Literature DB >> 17482114

Efficacy of silicated calcium phosphate graft in posterolateral lumbar fusion in sheep.

Donna L Wheeler1, Louis G Jenis, Matthew E Kovach, Jason Marini, A Simon Turner.   

Abstract

BACKGROUND CONTEXT: Conditions requiring posterior lumbar spinal fusion remain a clinical challenge. Achieving arthrodesis using autogenous bone graft is inconsistent when rigid internal fixation such as transpedicular instrumentation is applied. Synthetic materials, particularly calcium phosphate-based ceramics, have shown promise for spine fusion applications, especially when combined with autograft. Silicate substitution has been shown to enhance the bioactivity of calcium phosphates and may obviate the need for autologous supplementation.
PURPOSE: Determine efficacy of silicated calcium phosphate (Si-CaP) compared with autograft to generate solid lumbar fusion. STUDY
DESIGN: Comparison of healing of instrumented posterolateral lumbar fusion in ewes at 2 and 6 months using Si-CaP or iliac crest autograft.
METHODS: Eighteen skeletally mature ewes underwent implantation of either autograft or Si-CaP in the space spanning the L4-L5 transverse process. In vivo quantitative computed tomography (CT) scans were made at 2-month intervals and after euthanasia. Harvested spine segments were radiographed and biomechanically tested in bending at 6 months. Histological assessments were made at 2 and 6 months.
RESULTS: Animals receiving Si-CaP graft were biomechanically and radiographically equivalent to those receiving autograft. Fusion mass density and volume were higher for the Si-CaP group throughout the healing period. Si-CaP regenerated normal bone tissue morphology, cellularity, and maturation with no inflammatory responses despite the fact that no autograft, bone marrow aspirate, or blood was mixed with the material. Histomorphometrically, fusion mass was higher for Si-CaP and bony bridging was equivalent when compared with autograft treatment.
CONCLUSIONS: Si-CaP was biomechanically, radiographically, and histologically equivalent to autograft in generating a solid, bony, intertransverse process fusion in an ovine model. Both treatment groups achieved 100% bridging fusion after 6 months of healing.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17482114     DOI: 10.1016/j.spinee.2006.01.005

Source DB:  PubMed          Journal:  Spine J        ISSN: 1529-9430            Impact factor:   4.166


  11 in total

Review 1.  [Resorbable bone substitution materials: An overview of commercially available materials and new approaches in the field of composites].

Authors:  S Heinemann; M Gelinsky; H Worch; T Hanke
Journal:  Orthopade       Date:  2011-09       Impact factor: 1.087

Review 2.  Scaffold translation: barriers between concept and clinic.

Authors:  Scott J Hollister; William L Murphy
Journal:  Tissue Eng Part B Rev       Date:  2011-09-21       Impact factor: 6.389

Review 3.  An analysis of spine fusion outcomes in sheep pre-clinical models.

Authors:  Emily M Lindley; Cameron Barton; Thomas Blount; Evalina L Burger; Christopher M J Cain; Howard B Seim; A Simon Turner; Vikas V Patel
Journal:  Eur Spine J       Date:  2016-05-10       Impact factor: 3.134

4.  Silicate-substituted calcium phosphate with enhanced strut porosity stimulates osteogenic differentiation of human mesenchymal stem cells.

Authors:  Roberta Ferro De Godoy; Stacy Hutchens; Charlie Campion; Gordon Blunn
Journal:  J Mater Sci Mater Med       Date:  2015-01-18       Impact factor: 3.896

5.  Comparison of Two Synthetic Bone Graft Products in a Rabbit Posterolateral Fusion Model.

Authors:  Douglas Fredericks; Emily B Petersen; Nicole Watson; Nicole Grosland; Katherine Gibson-Corley; Joseph Smucker
Journal:  Iowa Orthop J       Date:  2016

6.  Assessment of SiCaP-30 in a Rabbit Posterolateral Fusion Model with Concurrent Chemotherapy.

Authors:  Joseph D Smucker; Emily B Petersen; Ali Al-Hili; James V Nepola; Douglas C Fredericks
Journal:  Iowa Orthop J       Date:  2015

7.  Spinal Fusion of an Unstable Atlantoaxial Fracture in a Completely Tetraplegic Patient Using Silicate-Substituted Calcium Phosphate.

Authors:  Cornelia Putz; Bernd Wiedenhöfer; Hans J Gerner; Karl Hüttinger; Carl H Fürstenberg
Journal:  Eur J Trauma Emerg Surg       Date:  2009-03-02       Impact factor: 3.693

8.  Silicate-substituted calcium phosphate as a bone graft substitute in surgery for adolescent idiopathic scoliosis.

Authors:  Thomas Lerner; Ulf Liljenqvist
Journal:  Eur Spine J       Date:  2012-09-05       Impact factor: 3.134

9.  Silicon Matrix Calcium Phosphate as a Bone Substitute: Early Clinical and Radiological Results in a Prospective Study With 12-Month Follow-up.

Authors:  Luiz Pimenta; Carlos Fernando Arias Pesántez; Leonardo Oliveira
Journal:  SAS J       Date:  2008-06-01

10.  Bone grafting options for lumbar spine surgery: a review examining clinical efficacy and complications.

Authors:  Kenneth Vaz; Kushagra Verma; Themistocles Protopsaltis; Frank Schwab; Baron Lonner; Thomas Errico
Journal:  SAS J       Date:  2010-09-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.